Per S. Bakke
- Are systemic inflammatory markers predictive of loss of lean body mass in COPD patients?By Tomas M.L. Eagan, Esteban Gabazza, Corina D'Alessandro-Gabazza, Jon A. Hardie, Per S. Bakke and Peter D. WagnerTomas M.L. EaganEsteban Gabazza3Department of Immunology, Mie University School of Medicine, Tsu City, Mie, JapanCorina D'Alessandro-Gabazza3Department of Immunology, Mie University School of Medicine, Tsu City, Mie, JapanJon A. Hardie1Department of Thoracic Medicine, Haukeland University Hospital, Bergen, NorwayPer S. Bakke2Institute of Medicine, Section for Pulmonology, University of Bergen, Bergen, NorwayPeter D. Wagner4Department of Medicine, Division of Physiology, University of California San Diego, La Jolla, CA, United States
- Predictors for developing hypoxic respiratory failure in COPD – A 3-year follow-upBy Eirunn Waatevik Saure, Tomas M.L. Eagan, Robert L. Jensen, Per S. Bakke, Marianne Voll-Aanerud, Einar Thorsen and Jon A. HardieEirunn Waatevik Saure1Institute of Medicine, University of Bergen, Bergen, NorwayTomas M.L. Eagan2Department of Thoracic Medicine, Haukeland University Hospital, Bergen, NorwayRobert L. Jensen3Internal Medicine, Pulmonary Division, University of Utah, Salt Lake City, UT, United StatesPer S. Bakke1Institute of Medicine, University of Bergen, Bergen, NorwayMarianne Voll-Aanerud2Department of Thoracic Medicine, Haukeland University Hospital, Bergen, NorwayEinar Thorsen1Institute of Medicine, University of Bergen, Bergen, NorwayJon A. Hardie1Institute of Medicine, University of Bergen, Bergen, Norway
- Predictors for longitudinal change in 6-minute walk distance in COPD patientsBy Bente Frisk, Birgitte Espehaug, Jon Andrew Hardie, Liv Inger Strand, Rolf Moe-Nilssen, Tomas M. Eagan, Per S. Bakke and Einar ThorsenBente Frisk1Center for Evidence Based Practice, Bergen University College, Bergen, Norway2Institute of Medicine, University of Bergen, NorwayBirgitte Espehaug1Center for Evidence Based Practice, Bergen University College, Bergen, NorwayJon Andrew Hardie2Institute of Medicine, University of Bergen, NorwayLiv Inger Strand4Dept. of Public Health and Primary Health Care, University of Bergen, NorwayRolf Moe-Nilssen4Dept. of Public Health and Primary Health Care, University of Bergen, NorwayTomas M. Eagan5Dept. of Thoracic Medicine, Haukeland University Hospital, Bergen, NorwayPer S. Bakke2Institute of Medicine, University of Bergen, NorwayEinar Thorsen2Institute of Medicine, University of Bergen, Norway3Dept. of Occupational Medicine, Haukeland University Hospital, Bergen, Norway
- Neutrophil gelatinase-associated lipocalin (NGAL) is associated with a reduced decline in FVC in male COPD patientsBy Gunnar R. Husebø, Marianne Aanerud, Thor Ueland, Jon A. Hardie, Per S. Bakke and Tomas M. EaganGunnar R. Husebø1Dept. of Thoracic Medicine, Haukeland University Hospital, Bergen, NorwayMarianne Aanerud1Dept. of Thoracic Medicine, Haukeland University Hospital, Bergen, NorwayThor Ueland2Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, NorwayJon A. Hardie3Dept. of Clinical Science, University of Bergen, Bergen, NorwayPer S. Bakke3Dept. of Clinical Science, University of Bergen, Bergen, NorwayTomas M. Eagan1Dept. of Thoracic Medicine, Haukeland University Hospital, Bergen, Norway3Dept. of Clinical Science, University of Bergen, Bergen, Norway
- Can intra-breath variations of reactance predict dyspneaBy Bernt B. Aarli, Peter M.A. Calverley, Tomas M.L. Eagan, Per S. Bakke and Jon A. HardieBernt B. Aarli1Department of Clinical Science, University of Bergen, Bergen, NorwayPeter M.A. Calverley2Clinical Science Centre, University Hospital Aintree, Liverpool, United KingdomTomas M.L. Eagan1Department of Clinical Science, University of Bergen, Bergen, NorwayPer S. Bakke1Department of Clinical Science, University of Bergen, Bergen, NorwayJon A. Hardie1Department of Clinical Science, University of Bergen, Bergen, Norway
- Variability of within-breath reactance in COPD patients and its association with dyspnoeaBy Bernt B. Aarli, Peter M.A. Calverley, Robert L. Jensen, Tomas M.L. Eagan, Per S. Bakke and Jon A. HardieArticle | Published in 2014 in European Respiratory JournalBernt B. Aarli1Institute of Clinical Science, University of Bergen, Bergen, Norway2Dept of Thoracic Medicine, Haukeland University Hospital, Bergen, NorwayPeter M.A. Calverley3Clinical Science Centre, University Hospital Aintree, Liverpool, UKRobert L. Jensen4LDS Hospital, Pulmonary Division, Salt Lake City, UT, USATomas M.L. Eagan1Institute of Clinical Science, University of Bergen, Bergen, Norway2Dept of Thoracic Medicine, Haukeland University Hospital, Bergen, NorwayPer S. Bakke1Institute of Clinical Science, University of Bergen, Bergen, NorwayJon A. Hardie1Institute of Clinical Science, University of Bergen, Bergen, Norway
- Interleukin-18 levels in induced sputum of stable and exacerbated COPD patientsBy Ingvild Haaland, Marianne Aanerud, Solveig Tangedal, Louise J. Persson, Per S. Bakke and Tomas M. EaganIngvild Haaland1Section for Thoracic Medicine, Department of Clinical Science, University of Bergen, Bergen, Norway2Department of Thoracic Medicine, Haukeland University Hospital, Bergen, NorwayMarianne Aanerud2Department of Thoracic Medicine, Haukeland University Hospital, Bergen, NorwaySolveig Tangedal2Department of Thoracic Medicine, Haukeland University Hospital, Bergen, NorwayLouise J. Persson2Department of Thoracic Medicine, Haukeland University Hospital, Bergen, NorwayPer S. Bakke1Section for Thoracic Medicine, Department of Clinical Science, University of Bergen, Bergen, NorwayTomas M. Eagan1Section for Thoracic Medicine, Department of Clinical Science, University of Bergen, Bergen, Norway2Department of Thoracic Medicine, Haukeland University Hospital, Bergen, Norway
- Variability of within-breath reactance in COPD patients and its association with dyspnoeaBy Bernt B. Aarli, Peter M.A. Calverley, Robert L. Jensen, Tomas M.L. Eagan, Per S. Bakke and Jon A. HardieBernt B. Aarli1Institute of Clinical Science, University of Bergen, Bergen, Norway2Dept of Thoracic Medicine, Haukeland University Hospital, Bergen, NorwayPeter M.A. Calverley3Clinical Science Centre, University Hospital Aintree, Liverpool, UKRobert L. Jensen4LDS Hospital, Pulmonary Division, Salt Lake City, UT, USATomas M.L. Eagan1Institute of Clinical Science, University of Bergen, Bergen, Norway2Dept of Thoracic Medicine, Haukeland University Hospital, Bergen, NorwayPer S. Bakke1Institute of Clinical Science, University of Bergen, Bergen, NorwayJon A. Hardie1Institute of Clinical Science, University of Bergen, Bergen, Norway
- The first U-BIOPRED blood handprint of severe asthmaBy Bertrand De Meulder, Diane Lefaudeux, Jeanette Bigler, Matthew J. Loza, Craig E. Wheelock, Ana R. Sousa, Julie Corfield, Frédéric Baribaud, Charles Auffray, Dominic E. Shaw, Ildiko Horvath, Jacek Musial, Pascal Chanez, Norbert Krug, Paolo Montuschi, Per S. Bakke, Florian Singer, Stephen J. Fowler, Sven-Erik Dahlen, Thomas Sandström, Peter J. Sterk, Kian Fan Chung, Ian M. Adcock, Ratko Djukanovic and The U-BIOPRED Working GroupBertrand De Meulder1European Institute for Systems Biology and Medicine (EISBM), CNRS - ENS - UCBL Université de Lyon, Lyon, Rhone FranceDiane Lefaudeux1European Institute for Systems Biology and Medicine (EISBM), CNRS - ENS - UCBL Université de Lyon, Lyon, Rhone FranceJeanette Bigler2Amgen, Amgen, Seattle, United StatesMatthew J. Loza3Systems Pharmacology and Biomarkers, Janssen R&D, Springhouse, United StatesCraig E. Wheelock4Bioanalytical Chemistry Research Laboratory in Inflammatory Metabolomics, Karolinska Institutet, Stockholm, SwedenAna R. Sousa5Discovery Medicine, GlaxoSmithKline, Uxbridge, United KingdomJulie Corfield6Arateva, Arateva Ltd., Nottingham, United KingdomFrédéric Baribaud3Systems Pharmacology and Biomarkers, Janssen R&D, Springhouse, United StatesCharles Auffray1European Institute for Systems Biology and Medicine (EISBM), CNRS - ENS - UCBL Université de Lyon, Lyon, Rhone FranceDominic E. Shaw7Faculty of Medicine and Health Sciences, Nottingham University Hospital, Nottingham, United KingdomIldiko Horvath8Pulmonology, Semmelweis University, Budapest, HungaryJacek Musial9Allergy and Immunology, Jagiellonian University, Krakow, PolandPascal Chanez10Clinique des Bronches, Allergie et Sommeil, Université de la Méditerranée, Marseille, FranceNorbert Krug11Immunology, Allergology and Clinical Inhalation, Fraunhofer Institute, Hannover, GermanyPaolo Montuschi12Pharmacology, Unniversità Cattolica del Sacro Cuore, Roma, ItalyPer S. Bakke13Thoracic Medicine, Haukeland University Hospital, Bergen, NorwayFlorian Singer14Paediatric Respiratory Medicine, University Hospital, Inselpital, Bern, SwitzerlandStephen J. Fowler15Respiratory Research Group, University of Manchester, Manchester, United KingdomSven-Erik Dahlen16Experimental Asthma and Allergy Research, Karolinska Institutet, Stockholm, SwedenThomas Sandström17Pulmonology, University Hospital, Umea, SwedenPeter J. Sterk18Pulmonology, Academisch Medisch Centrum, Amsterdam, NetherlandsKian Fan Chung19National Hearth & Lung Institute, Imperial College London, London, United KingdomIan M. Adcock19National Hearth & Lung Institute, Imperial College London, London, United KingdomRatko Djukanovic20National Institute for Health Research Respiratory Biomedical Research Unit, University of Southampton, Southampton, United Kingdom1European Institute for Systems Biology and Medicine (EISBM), CNRS - ENS - UCBL Université de Lyon, Lyon, Rhone France
- Can the influenza vaccine response be predicted in COPD patients by clinical parameters?By Tomas M.L. Eagan, Jon A. Hardie, Åsne Jul-Larsen, Per S. Bakke and Rebecca J. CoxTomas M.L. Eagan1Dept. of Thoracic Medicine, Haukeland University Hospital, Bergen, Norway2Dept. of Clinical Science, University of Bergen, Bergen, NorwayJon A. Hardie2Dept. of Clinical Science, University of Bergen, Bergen, NorwayÅsne Jul-Larsen2Dept. of Clinical Science, University of Bergen, Bergen, NorwayPer S. Bakke2Dept. of Clinical Science, University of Bergen, Bergen, NorwayRebecca J. Cox2Dept. of Clinical Science, University of Bergen, Bergen, Norway
- The first U-BIOPRED sputum handprint of severe asthmaBy Diane Lefaudeux, Bertrand De Meulder, Matthew J. Loza, Marek Sanak, Ana R. Sousa, Julie Corfield, Frédéric Baribaud, Dominic E. Shaw, Ildiko Horvath, Jacek Musial, Pascal Chanez, Norbert Krug, Paolo Montuschi, Per S. Bakke, Florian Singer, Stephen J. Fowler, Sven-Erik Dahlén, Thomas Sandström, Peter J. Sterk, Ratko Djukanovic, Kian Fan Chung, Ian M. Adcock, Charles Auffray and The U-BIOPRED Study GroupDiane Lefaudeux1EISBM, CNRS - ENS - UCBL, Lyon, FranceBertrand De Meulder1EISBM, CNRS - ENS - UCBL, Lyon, FranceMatthew J. Loza2Systems Pharmacology & Biomarkers, Janssen Research and Development, Springhouse, United StatesMarek Sanak3'Molecular Biology and Clinical Genetics' and 'Allergy and Immunology', Jagiellonian University Medical College, Krakow, PolandAna R. Sousa4Discovery Medicine, GlaxoSmithKline, Uxbridge, United KingdomJulie Corfield5Areteva, Arateva Ltd, Nottingham, United KingdomFrédéric Baribaud2Systems Pharmacology & Biomarkers, Janssen Research and Development, Springhouse, United StatesDominic E. Shaw6Faculty of Medicine & Health Sciences, Nottingham University Hospital, Nottingham, United KingdomIldiko Horvath7Pulmonology, Semmelweis University, Budapest, HungaryJacek Musial3'Molecular Biology and Clinical Genetics' and 'Allergy and Immunology', Jagiellonian University Medical College, Krakow, PolandPascal Chanez8Clinique des Bronches, Allergie et Sommeil, Université de la Méditerranée, Marseille, FranceNorbert Krug9Immunology, Allergology and Clinical Inhalation, Fraunhofer Institute, Hannover, GermanyPaolo Montuschi10Pharmacology, Università Cattolica del Sacro Cuore, Roma, ItalyPer S. Bakke11Thoracic Medicine, Haukeland University Hospital, Bergen, NorwayFlorian Singer12Pulmonology, University Hospital, Inselspital, Bern, SwitzerlandStephen J. Fowler13Respiratory Research Group, University of Manchester, Manchester, SwedenSven-Erik Dahlén14Experimental Asthma and Allergy Research, Karolinska Institutet, Stockholm, SwedenThomas Sandström15Pulmonology, University Hospital, Umea, SwedenPeter J. Sterk16Academic Medical Center, University of Amsterdam, Amsterdam, NetherlandsRatko Djukanovic17NHS Foundation Trust, University Hospital Southampton, Southampton, United KingdomKian Fan Chung18National Heart & Lung Institute, Imperial College London, London, United KingdomIan M. Adcock18National Heart & Lung Institute, Imperial College London, London, United KingdomCharles Auffray1EISBM, CNRS - ENS - UCBL, Lyon, France1EISBM, CNRS - ENS - UCBL, Lyon, France
- MIG and IP-10 levels in induced sputum of stable and exacerbated COPD patientsBy Solveig Tangedal, Marianne Aanerud, Louise J.P. Persson, Per S. Bakke and Tomas M.L. EaganSolveig Tangedal1Departement of Thoracic Medicine, Haukeland University Hospital, Bergen, NorwayMarianne Aanerud2Departement of Medicine, Haukeland University Hospital, Bergen, NorwayLouise J.P. Persson1Departement of Thoracic Medicine, Haukeland University Hospital, Bergen, NorwayPer S. Bakke3Departement of Clinical Science, University of Bergen, Bergen, NorwayTomas M.L. Eagan1Departement of Thoracic Medicine, Haukeland University Hospital, Bergen, Norway3Departement of Clinical Science, University of Bergen, Bergen, Norway
- Peak oxygen uptake and breathing pattern in COPD patients – A four year longitudinal studyBy Bente Frisk, Jon A. Hardie, Birgitte Espehaug, Liv I. Strand, Rolf Moe-Nilssen, Tomas M.L. Eagan, Per S. Bakke and Einar ThorsenBente Frisk1Centre for Evidence-Based Practice, Bergen University College, Bergen, Norway2Dept. of Clinical Science, University of Bergen, Bergen, NorwayJon A. Hardie2Dept. of Clinical Science, University of Bergen, Bergen, NorwayBirgitte Espehaug1Centre for Evidence-Based Practice, Bergen University College, Bergen, NorwayLiv I. Strand3Dept. of Global Public Health and Primary Care, University of Bergen, Bergen, Norway4Dept. of Physiotherapy, Haukeland University Hospital, Bergen, NorwayRolf Moe-Nilssen3Dept. of Global Public Health and Primary Care, University of Bergen, Bergen, NorwayTomas M.L. Eagan2Dept. of Clinical Science, University of Bergen, Bergen, Norway5Dept. of Thoracic Medicine, Haukeland University Hospital, Bergen, NorwayPer S. Bakke2Dept. of Clinical Science, University of Bergen, Bergen, NorwayEinar Thorsen2Dept. of Clinical Science, University of Bergen, Bergen, Norway6Dept. of Occupational Medicine, Haukeland University Hospital, Bergen, Norway
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, and a companion volume of self-assessment questions is available. In 2015, the first ERS Practical Handbook, on Noninvasive Ventilation, was added to the series
